Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells

Journal of Neurochemistry

Volumn 68, Issue 6, 1997, Pages 2328-2337

  Posmantur, Rand ^a   McGinnis, Kim ^a   Nadimpalli, Ravi ^a   Gilbertsen, Richard B ^a   Wang, Kevin K W ^a  

^a PFIZER INC   (United States)

Author keywords

Apoptosis; CPP32; Human SH SY5Y neuroblastoma cells; Interleukin 1 converting enzyme like proteases; Poly(ADP ribose) polymerase

Indexed keywords

INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEINASE;

APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CELL MATURATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING;

EID: 0031011697     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68062328.x     Document Type: Article

References (54)

1. Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thornberry N. A., Wong W. W., and Yuan J. (1996) Human ICE/CED-3 protease nomenclature. Cell 87, 171.
2. Brown D. G., Sun X. M., and Cohen G. M. (1993) Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268, 3037-3039.
3. Casciola-Rosen L., Nicholson D. W., Chong T., Rowan K. R., Thornberry N. A., Miller D. K., and Rosen A. (1996) Apopain/ CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183, 1957-1964.
4. Cerretti P. G., Kozlosky C. J., Mosley B., Nelson N., Ness K. V., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizzaro L. A., Huebner K., and Black R. A. (1992) Molecular cloning of the interleukin-1β converting enzyme. Science 256, 97-101.
5. Darmon A. J., Ehrman N., Caputo A., Fujinaga J., and Bleackley R. C. (1994) The cytotoxic T cell proteinase granzyme B does not activate interleukin-1-beta-converting enzyme. J. Biol. Chem. 269, 32043-32050.
6. Datta R., Banach D., Kojima H., Talanian R. V., Alnemri E. S., Wong W. W., and Kufe D. W. (1996) Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine. Blood 88, 1936-1943.
7. 1 aspartate-based peptide α-((2,6-dichlorobenzoyl)oxy) methyl ketones as potent time-dependent inhibitors of interleukin-1β-converting enzyme. J. Med. Chem. 37, 563-564.
8. Enari M., Hug H., and Nagata S. (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78-81.
9. Enari M., Hug H., Hayakawa M., Ito F., Nishimura Y., and Nagata S. (1996) Different apoptotic pathways mediated by Fas and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in Fas-mediated apoptosis. Eur. J. Biochem. 236, 533-538.
10. Fernandes-Alnemri T., Litwack G., and Alnemri E. (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian 1-β converting enzyme. J. Biol. Chem. 269, 30761-30764.
11. Fernandes-Alnemri T., Takahashi A., Armstrong R., Krebs J., Fritz L., Tomaselli K. J., Wang L., Yu Z., Croce C. M., Salveson G., Earnshaw W. C., Litwack G., and Alnemri E. S. (1995) Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55, 6045-6052.
12. Fernandes-Alnemri T., Armstrong R. C., Krebs J., Srinivasula S. M., Wang L., Bullrich F., Fritz L. C., Trapani J. A., Tomaselli K. J., Litwack G., and Alnemri E. S. (1996) In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469.
13. Fraser A. and Evan G. (1996) A license to kill. Cell 85, 781-784.
14. Gavrieli Y., Sherman Y., and Ben-Sasson S. (1992) Identification of programmed cell death. Early synthesis and DNA degradation. J. Cell Biol. 119, 493-501.
15. Goldberg Y. P., Nicholson D. W., Rasper D. M., Kalchman M. A., Koide H. B., Graham R. K., Bromm M., Kazemi-Esfarjani P., Thornberry N. A., Vaillancourt J. P., and Hayden M. R. (1996) Cleavage of huntingtin by apopain, in a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet. 13, 442-449.
16. Gschwind M., Martin J. R., Moreau J. L., and Huber G. (1996) Beta APP cognitive function vs. beta-amyloid induced cell death. Ann. NY Acad. Sci. 777, 293-296.
17. Hill I. E., MacManus J. P., Rasquinha I., and Tuor U. I. (1995) DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 676, 398-403.
18. Homma S., Yaginuma H., and Oppenheim R. W. (1994) Programmed cell death during the earliest stages of spinal cord development in the chick embryo: a possible means of early phenotypic selection. J. Comp. Neurol. 345, 377-395.
19. Jacobson M. D., Weil M., and Raff M. C. (1996) Role of Ced-3/ ICE-family in staurosporine induced programmed cell death. J. Cell Biol. 133, 1041-1051.
20. Kerr J. F. R. and Harmon B. V. (1991) Definition and incidence of apoptosis: an historical perspective, in Apoptosis: The Molecular Basis of Cell Death (Tomeiand L. D. and Cope F. O., eds), p. 5. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
21. Koh J. Y., Wie M. B., Sensi S. L., Canzoniero L. M., Demaro L., Cernansky C., and Choi D. W. (1995) Staurosporine-induced neuronal apoptosis. Exp. Neurol. 135, 153-159.
22. Kuida K., Lippke J. A., Ku G., Harding M. W., Livingston D. J., Su M. S., and Flavell R. A. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267, 2000-2003.
23. Kuida K., Zheng T., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., and Flavell A. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-370.
24. Lazebnik Y. A., Kaufman S. H., Desnoyers S., Poirier G. G., and Earnshaw W. C. (1994) Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
25. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L., Salfeld J., Towne E., Tracey D., Wardwell S., Wei F.-Y., Wong W., Kamen R., and Seshadri T. (1995) Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxin shock. Cell 80, 401-411.
26. Linnik M. D., Zobrist R. H., and Hatfield M. D. (1993) Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24, 2002-2008.
27. MacManus J. P., Buchan A. M., Hill I. E., Rasquinha I., and Preston E. (1993) Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 164, 89-92.
28. Martin S. J. and Green D. R. (1995) Protease activation during apoptosis: death by a thousand cuts? Cell 82, 349-352.
29. Martin S. J., O'Brien G. A., Nishioka W. K., McGahon A. J., Mahboubia T., Saido T. C., and Green D. (1995) Proteolysis of fodrin during apoptosis. J. Biol. Chem. 270, 6425-6428.
30. Marx J. (1996) Mutant enzyme provides new insights into the cause of ALS. Science 272, 446-447.
31. Miura M., Zhu H., Rotello R., Hartwieg E. A., and Yuan J. (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene Ced-3. Cell 75, 653-660.
32. Nath R., Raser K. J., Stafford D., Hajimohammadreza I., Posner A., Allen H., Talanian R., Yuen P. Y., Gilbertsen R. B., and Wang K. W. (1996) Non-erythroid α-spectrin breakdown by calpain and interleukin 1B-converting enzyme like proteases in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 318, 683-690.
33. Nicholson D. W., Ambereen A. N., Thornberry N. A., Vaillancourt J. P., Ding, C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T.-T., Yu V. L., and Miller D. K. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
34. Nixon R. A., Saito K. I., Grynspan F., Griffin W. R., Katayama S., Honda T., Mohan P. S., Shea T. B., and Beermann M. (1994) Calpain activated neutral protease (calpain) system in aging and Alzheimer's disease. Ann. NY Acad. Sci. 747, 77-91.
35. Orth K., O'Rourke K., Salvesen G. S., and Dixit V. M. (1996) Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J. Biol. Chem. 271, 20977-20980.
36. Portera-Cailliau C., Hedreen J. C., Price D. L., and Koliatsos V. E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
37. Satou T., Cummings B. J., and Cotman C. W. (1995) Immunoreactivity for BC1-2 protein with neurons in the Alzheimers disease brain increases with disease severity. Brain Res. 697, 35-43.
38. Schlegel J., Peters I., Orrenius S., Miller D. M., Thornberry N. A., Yamin Y. Y., and Nicholson D. W. (1996) CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271, 1841-1844.
39. Srinivasula S. M., Ahmad M., Fernandes-Alnemri T., Litwack G., and Alnemri E. (1996) Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple CED-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 93, 14486-14491.
40. Tewari M. and Dixit V. M. (1995) Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260.
41. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Bedler D. R., Poirier S. S., and Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456.
42. Thornberry N. A., Herbert G. B., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J., et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1B processing in monocytes. Nature 356, 768-774.
43. Troost D., Aten J., Morsink F., and de-long J. M. (1995) Apoptosis in ALS is not restricted to motor neurons: Bcl-2 expression increased in post-central cortex, adjacent to the affected motor cortex. J. Neurol. Sci. 129, 79-80.
44. Vanags D. M., Porn-Ares M. I., Coppola S., Burgess D. H., and Orrenius S. (1996) Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271, 31075-31081.
45. Vaux D. L. and Strasser A. (1996) The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93, 2239-2244.
46. 2+ binding protein ALG-2 and Alzheimers disease gene ALG-3. Science 271, 521-525.
47. Walkinshaw G. and Waters C. M. (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest. 95, 2458-2464.
48. Weil M., Jacobson M. D., Coles H. S., Davies T. J., Gardner R. L., and Raff M. C. (1996) Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133, 1053-1059.
49. Wiesner D. A. and Dawson G. (1996) Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66, 1418-1425.
50. Yaginuma H., Tomita M., Takashita N., McKay S. E., Cardwell C., Yin Q. W., and Oppenheim R. W. (1996) A novel type of programmed neuronal death in the cervical spinal cord of the chick embryo. J. Neurosci. 16, 3685-3703.
51. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., et al. (1996) G-protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272, 1349-1352.
52. Zamenhof S. and Guthrie D. (1995) Programmed cell death enhances uniformity in rat cerebral hemispheres. Dev. Neurosci. 17, 264-266.
53. Zeitlin S., Liu J. P., Chapman D. L., Papaioannou V. E., and Efstratiadis A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11, 155-163.
54. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., and Barzilai A. (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci. Lett. 170, 136-140.